Showing results (151-160 of 237) with videos related to
Sort By:
Pageof 24
The Oncologist|July 13, 2013
AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumorsElizabeth R Plimack, Patricia M Lorusso, Patricia McCoon, et al.Cancer Chemotherapy and Pharmacology|February 15, 2019
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancerToshio Kawata, Mitsuo Higashimori, Yohji Itoh, et al.British Journal of Clinical Pharmacology|April 14, 2023
Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodiesJavier Reig-Lopez, Weifeng Tang, Carlos Fernandez-Teruel, et al.Clinical Therapeutics|March 18, 2018
Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian SubjectsYunona Khomitskaya, Nadezhda Tikhonova, Konstantin Gudkov, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|April 7, 2016
Forkhead box A1 (FOXA1) tagging polymorphisms and esophageal cancer risk in a Chinese population: a fine-mapping studyMingna Li, Wenbo Zhang, Chao Liu, et al.DNA and Cell Biology|March 20, 2019
Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese PopulationJun Liu, Weifeng Tang, Wanzun Lin, et al.Cytokine & Growth Factor Reviews|April 18, 2026
The immunodynamics of pulmonary fibrosisCong Xie, Yuanyuan Ma, Yunjing Wang, et al.Frontiers in Medicine|May 29, 2026
Small airway dysfunction: a shared, early, measurable, and potentially treatable trait across COPD, asthma, and fibrotic lung diseaseCong Xie, Kai Yang, Weifeng Tang, et al.Scientific Reports|February 16, 2022
Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese populationYan Wang, Zhiyuan Qiu, Guangyu Tian, et al.Journal of Clinical Pharmacology|October 17, 2021
Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling AnalysisHongtao Yu, Sanchita Basu, Weifeng Tang, et al.Pageof 24